These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2900533)

  • 1. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.
    Kaye WH; Rubinow D; Gwirtsman HE; George DT; Jimerson DC; Gold PW
    Psychoneuroendocrinology; 1988; 13(3):265-72. PubMed ID: 2900533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia.
    Gwirtsman HE; Kaye WH; George DT; Jimerson DC; Ebert MH; Gold PW
    Arch Gen Psychiatry; 1989 Jan; 46(1):61-9. PubMed ID: 2535925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia.
    Walsh BT; Roose SP; Katz JL; Dyrenfurth I; Wright L; Vande Wiele R; Glassman AH
    Psychoneuroendocrinology; 1987; 12(2):131-40. PubMed ID: 3037583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA; Rubinow DR; Doran AR; Roy A; Davis CL; Calabrese JR; Nieman LK; Post RM; Chrousos GP; Gold PW
    Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.
    Kaye WH; Gwirtsman HE; George DT; Ebert MH; Jimerson DC; Tomai TP; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1987 Feb; 64(2):203-8. PubMed ID: 3491830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.
    Demitrack MA; Lesem MD; Listwak SJ; Brandt HA; Jimerson DC; Gold PW
    Am J Psychiatry; 1990 Jul; 147(7):882-6. PubMed ID: 2356873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbances in the hypothalamo-pituitary-adrenal and other neuroendocrine axes in bulimia.
    Fichter MM; Pirke KM; Pöllinger J; Wolfram G; Brunner E
    Biol Psychiatry; 1990 May; 27(9):1021-37. PubMed ID: 2110485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I; Bissette G; Dettling M; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Nemeroff CB; Holsboer F
    Depress Anxiety; 1998; 8(2):71-9. PubMed ID: 9784981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin, prolactin, and growth hormone responses to thyrotropin-releasing hormone in anorexia nervosa and bulimia.
    Kiriike N; Nishiwaki S; Izumiya Y; Maeda Y; Kawakita Y
    Biol Psychiatry; 1987 Feb; 22(2):167-76. PubMed ID: 3101755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa.
    Frank GK; Kaye WH; Ladenheim EE; McConaha C
    Appetite; 2001 Aug; 37(1):9-14. PubMed ID: 11562153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa.
    Duclos M; Corcuff JB; Roger P; Tabarin A
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):725-31. PubMed ID: 10619977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.
    Hotta M; Shibasaki T; Masuda A; Imaki T; Demura H; Ling N; Shizume K
    J Clin Endocrinol Metab; 1986 Feb; 62(2):319-24. PubMed ID: 3001125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
    J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa.
    Kaye WH; Berrettini WH; Gwirtsman HE; Chretien M; Gold PW; George DT; Jimerson DC; Ebert MH
    Life Sci; 1987 Nov; 41(18):2147-55. PubMed ID: 2823041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bulimia nervosa--a primary defect in the hypothalamic-pituitary-adrenal axis?
    Birketvedt GS; Drivenes E; Agledahl I; Sundsfjord J; Olstad R; Florholmen JR
    Appetite; 2006 Mar; 46(2):164-7. PubMed ID: 16499999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients.
    Widerlöv E; Bissette G; Nemeroff CB
    J Affect Disord; 1988; 14(2):99-107. PubMed ID: 2452842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients.
    Gold PW; Gwirtsman H; Avgerinos PC; Nieman LK; Gallucci WT; Kaye W; Jimerson D; Ebert M; Rittmaster R; Loriaux DL
    N Engl J Med; 1986 May; 314(21):1335-42. PubMed ID: 3010109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol.
    Putignano P; Dubini A; Toja P; Invitti C; Bonfanti S; Redaelli G; Zappulli D; Cavagnini F
    Eur J Endocrinol; 2001 Aug; 145(2):165-71. PubMed ID: 11454512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone.
    Vythilingam M; Anderson GM; Owens MJ; Halaszynski TM; Bremner JD; Carpenter LL; Heninger GR; Nemeroff CB; Charney DS
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4138-45. PubMed ID: 11095445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.